Anaïs M. Quéméner

Gain-of-function CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and therapy-resistance

D. Gilot, M. Aubry, J. Marine, 2020, bioRxiv.

Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16

D. Gilot, M. Aubry, F. Mouriaux, 2022, Life Science Alliance.

Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development

Anaïs M. Quéméner, M. L. Centomo, Riccardo Panella, 2022, Molecules.

The powerful world of antisense oligonucleotides: From bench to bedside

D. Gilot, M. Galibert, L. Bachelot, 2020, Wiley interdisciplinary reviews. RNA.

CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance

D. Gilot, M. Aubry, J. Marine, 2021, EMBO molecular medicine.

Antisense oligonucleotide: A promising therapeutic option to beat COVID‐19

M. Galibert, Anaïs M. Quéméner, 2021, Wiley interdisciplinary reviews. RNA.